EMAIL THIS PAGE TO A FRIEND

Endocrinology

Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy.


PMID 24684303

Abstract

Previous studies have indicated that adiponectin (APN) protects against cardiac remodeling, but the underlying mechanism remains unclear. The present study aimed to elucidate how APN regulates inflammatory responses and cardiac fibrosis in response to angiotensin II (Ang II). Male APN knockout (APN KO) mice and wild-type (WT) C57BL/6 littermates were sc infused with Ang II at 750 ng/kg per minute. Seven days after Ang II infusion, both APN KO and WT mice developed equally high blood pressure levels. However, APN KO mice developed more severe cardiac fibrosis and inflammation compared with WT mice. This finding was demonstrated by the up-regulation of collagen I, α-smooth muscle actin, IL-1β, and TNF-α and increased macrophage infiltration in APN KO mice. Moreover, there were substantially fewer microtubule-associated protein 1 light chain 3-positive autophagosomes in macrophages in the hearts of Ang II-infused APN KO mice. Additional in vitro studies also revealed that globular APN treatment induced autophagy, inhibited Ang II-induced nuclear factor-κB activity, and enhanced the expression of antiinflammatory cytokines, including IL-10, macrophage galactose N-acetyl-galactosamine specific lectin 2, found in inflammatory zone 1, and type-1 arginase in macrophages. In contrast, APN-induced autophagy and antiinflammatory cytokine expression was diminished in Atg5-knockdown macrophages or by Compound C, an inhibitor of adenosine 5'-monophosphate-activated protein kinase. Our study indicates that APN activates macrophage autophagy through the adenosine 5'-monophosphate-activated protein kinase pathway and suppresses Ang II-induced inflammatory responses, thereby reducing the extent of cardiac fibrosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA000440
Anti-CD45 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW21465 Anti-PTPRC antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
G0750
D-(+)-Galactose, ≥99%
C6H12O6
G0625
D-(+)-Galactose, ≥98%
C6H12O6
G6404
D-(+)-Galactose, BioXtra, pH 5.0-7.0 (20 °C, 1 M in H2O), ≥99%
C6H12O6
G5388
D-(+)-Galactose, powder, anhydrous, BioReagent, suitable for cell culture, suitable for insect cell culture
C6H12O6
48260
D-(+)-Galactose, for microbiology, ≥99.0%
C6H12O6
15522
D-(+)-Galactose, meets analytical specification of Ph. Eur., BP
C6H12O6
1287700 Galactose, United States Pharmacopeia (USP) Reference Standard
C6H12O6
PHR1206
Galactose, Pharmaceutical Secondary Standard; Certified Reference Material
C6H12O6
G0050000
Galactose, European Pharmacopoeia (EP) Reference Standard
C6H12O6
ARK2176
Galactose, plant-derived, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C6H12O6
SAB4700471 Monoclonal Anti-CD45 antibody produced in mouse, clone MEM-28, purified immunoglobulin, buffered aqueous solution
AMAB90518
Monoclonal Anti-CD45 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0159, purified immunoglobulin, buffered aqueous glycerol solution
AMAB90519
Monoclonal Anti-CD45 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0160, purified immunoglobulin, buffered aqueous glycerol solution
SAB4700587 Monoclonal Anti-CD45 antibody produced in rat, clone EM-05, purified immunoglobulin, buffered aqueous solution
SAB4700649 Monoclonal Anti-PTPRC antibody produced in mouse, clone IVA103, purified immunoglobulin, buffered aqueous solution